NCT06259383View on ClinicalTrials.gov

Oral Ivermectin for Chikungunya Viral Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 31, 2021

Study Completion Date

January 26, 2024

Conditions
Clinical Syndrome
Interventions
DRUG

Ivermectin

3-day 1 daily dose of 400 μg/kg oral ivermectin

Trial Locations (1)

90110

Prince of Songkla University, Hat Yai

All Listed Sponsors
lead

Prince of Songkla University

OTHER

NCT06259383 - Oral Ivermectin for Chikungunya Viral Infection | Biotech Hunter | Biotech Hunter